Last updated: 2026-09-16 11:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
TELA Bio, Inc. (TELA) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1,08, with a market capitalisation of $46,69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,50 to $1,69. This page covers its latest market performance, valuation, price trends and company information.
$46,69M | |
$1,08 | |
$23,55 | |
$0,50 | |
$1,09 | |
544,00 | |
178,07K | |
-- | |
$1,69 | |
$0,50 | |
-- | |
-- |
TELA Bio, Inc. (TELA) is trading at $1,08 in pre-market trading as of 2026-09-16 08:04:00, down 0,92% ($0,01) from the previous close of $1,09
Pre-market trading shows how investors are pricing TELA before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, TELA Bio, Inc. (TELA) moved from $0,82 to $1,08, representing a gain of 31,47% ($0,26).
The stock traded between $0,79 and $1,10 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 228,99 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 48,9%
TELA is currently trading at $1,08, placing it 48,9% of the way from its 52-week low of $0,50 to its 52-week high of $1,69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 218 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of TELA Bio, Inc. (TELA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.